International Multispeciality Journal of Health - Japan 日本の医学雑誌 | 日本医学研究 | Regenerative Medicine | Clinical Excellence
Top Medical Journal in Japan | 日本のトップ医学雑誌
ISSN: 2395-6291 | R Impact Factor: 3.83 | DOI: 10.25125/medical-journal | Indexed in CrossRef, Google Scholar, J-STAGE (in progress), WorldCat
Medical Research Landscape in Japan: Key Statistics
Medical Research Publications
Annually
Pharmaceutical Research
Centers
Medical Schools
Nationwide
Annual Health Research
Investment
Source: Japan Agency for Medical Research and Development (AMED), Ministry of Health, Labour and Welfare, Japan Society for the Promotion of Science, 2024 Research Report
Medical Research Landscape in Japan | 日本の医学研究の状況
Japan, with a population of over 125 million, is a global leader in medical and pharmaceutical research, renowned for its contributions to regenerative medicine, cancer research, and neuroscience. The country's aging population (over 28% aged 65+) has driven significant investment in geriatric medicine, dementia research, and age-related disease prevention. Through initiatives like the Japan Agency for Medical Research and Development (AMED), the Innovation Japan program, and the Super Aging Society research framework, Japan continues to advance medical science across all domains, from basic research to clinical applications and traditional Japanese medicine (Kampo).
Regenerative Medicine & Stem Cells | 再生医療と幹細胞
Japan is a world leader in regenerative medicine, with pioneering research in iPS cells (induced pluripotent stem cells), for which Professor Shinya Yamanaka won the Nobel Prize. The country has established a favorable regulatory framework for regenerative medicine clinical applications.
Kampo & Traditional Japanese Medicine | 漢方医学
Kampo, the Japanese adaptation of Traditional Chinese Medicine, has been integrated into Japan's national healthcare system since 1967. There are 148 Kampo formulas approved as prescription drugs, with ongoing research to validate their efficacy through modern scientific methods.
About IMJ Health: Your Partner in Medical Research | 医学研究のパートナー
The International Multispeciality Journal of Health (IMJ Health) is a prestigious, peer-reviewed, open-access journal dedicated to advancing medical and pharmaceutical sciences globally. We provide Japanese researchers, clinicians, and healthcare professionals with a respected platform to publish their groundbreaking findings and contribute to the global medical community.
With our commitment to quality, speed, and visibility, IMJ Health ensures that research from Japan reaches a worldwide audience, fostering collaboration and knowledge exchange that addresses both local and global health challenges. Our journal aims to be accessible through J-STAGE (Japan Science and Technology Information Aggregator) and other major databases.
Open Access
オープンアクセスRapid Review
4-6 weeks | 4-6週間Global Indexing
J-STAGE (in progress)Top Japanese Institutions Publishing in IMJ Health | 日本の主要研究機関
Researchers from these leading Japanese institutions have published their work in IMJ Health:
- University of Tokyo (東京大学)
- Kyoto University (京都大学)
- Osaka University (大阪大学)
- Tohoku University (東北大学)
- Nagoya University (名古屋大学)
- Kyushu University (九州大学)
- Hokkaido University (北海道大学)
- Keio University (慶應義塾大学)
- Tokyo Medical and Dental University (東京医科歯科大学)
Japan's Medical Research Priorities | 日本の医学研究の優先分野
The Japan Agency for Medical Research and Development (AMED) and Ministry of Health, Labour and Welfare have identified key priority areas:
Regenerative Medicine & Cell Therapy | 再生医療と細胞治療
- iPS cell research and clinical applications
- Stem cell therapies for neurodegenerative diseases
- CAR-T cell therapy and cancer immunotherapy
- Organoid and 3D tissue engineering
- Regenerative medicine regulatory science
Neuroscience & Dementia Research | 神経科学と認知症研究
- Alzheimer's disease and dementia prevention
- Parkinson's disease research
- Brain-machine interfaces
- Neurodegenerative disease biomarkers
- Aging brain research
Cancer Research & Immunology | がん研究と免疫学
- Immuno-oncology and checkpoint inhibitors
- Precision cancer medicine
- Gastric and colorectal cancer research
- Liquid biopsy and early detection
- Pediatric cancer research
Pharmaceutical Innovation | 医薬品イノベーション
- Next-generation drug discovery platforms
- Antibody-drug conjugates (ADCs)
- Nucleic acid therapeutics
- Kampo and natural product research
- Drug delivery systems
AI & Digital Health | AIとデジタルヘルス
- AI-assisted diagnostic imaging
- Medical big data analytics
- Telemedicine and remote care systems
- Robotic surgery and medical devices
- Wearable health monitoring
Kampo & Traditional Medicine | 漢方医学
- Evidence-based Kampo research
- Mechanism studies of Kampo formulas
- Integration of Kampo with modern medicine
- Kampo for age-related diseases
- Quality control and standardization
Kampo & Traditional Japanese Medicine | 漢方医学
Kampo (漢方医学) is the Japanese adaptation of Traditional Chinese Medicine, developed over centuries and uniquely tailored to Japanese culture and healthcare needs. Since 1967, 148 Kampo formulas have been approved as prescription drugs covered by Japan's national health insurance. The Japan Society for Oriental Medicine (JSOM) and the National Institute of Biomedical Innovation (NIBIO) promote evidence-based Kampo research, integrating traditional wisdom with modern scientific validation.
漢方研究
Rikkunshito (六君子湯)
Gastrointestinal disorders, appetite stimulation, chemotherapy-induced nausea | 消化器症状、食欲不振
Daikenchuto (大建中湯)
Post-operative ileus, abdominal pain, intestinal motility | 術後腸閉塞、腹痛
Hachimijiogan (八味地黄丸)
Age-related symptoms, urinary disorders, diabetes complications | 加齢症状、排尿障害
Goshajinkigan (牛車腎気丸)
Diabetic neuropathy, lower back pain, urinary frequency | 糖尿病性神経障害、腰痛
Yokukansan (抑肝散)
Dementia-related behavioral symptoms, irritability, insomnia | 認知症の周辺症状、不眠
Shosaikoto (小柴胡湯)
Chronic hepatitis, inflammatory conditions | 慢性肝炎、炎症性疾患
Leading Medical Research Institutions in Japan | 日本の主要医学研究機関
- RIKEN Center for Integrative Medical Sciences (IMS)
- Japan Agency for Medical Research and Development (AMED)
- National Cancer Center Japan (NCC)
- National Cerebral and Cardiovascular Center (NCVC)
- National Center for Geriatrics and Gerontology (NCGG)
- Institute of Medical Science, University of Tokyo (IMSUT)
- CiRA (Center for iPS Cell Research and Application), Kyoto University
- National Institute of Infectious Diseases (NIID)
- National Institute of Biomedical Innovation (NIBIO)
- Japan Society for the Promotion of Science (JSPS)
Why Japanese Researchers Choose IMJ Health | 日本の研究者がIMJ Healthを選ぶ理由
Rigorous Peer Review
Double-blind peer review ensures quality, reliability, and credibility of published research, enhancing your academic reputation.
High Visibility & Impact
Indexed in Google Scholar, CrossRef, WorldCat, and Index Copernicus, with J-STAGE indexing in progress, ensuring global visibility.
Rapid Publication
Efficient editorial workflow with average publication time of 4-6 weeks from submission to online publication.
CrossRef DOI Registration
Every published article receives a unique DOI, ensuring permanent accessibility and citation tracking.
Frequently Asked Questions | よくある質問
Comprehensive FAQ for Japanese Authors | 日本の著者向けFAQ
Find answers about submission process, peer review, publication fees, J-STAGE indexing status, and more for Japanese medical researchers.
The average time from submission to publication is 4-6 weeks for articles from Japanese researchers. Our streamlined peer review process ensures rapid publication without compromising quality.
Yes, IMJ Health is indexed in Google Scholar, CrossRef, WorldCat, and Index Copernicus. We are actively pursuing indexing in J-STAGE (Japan Science and Technology Information Aggregator) to increase visibility for Japanese researchers and ensure recognition for academic promotions and funding requirements from Japanese institutions.
Current Indexing Status | 現在のインデックス状況:
- Google Scholar | グーグルスカラー
- CrossRef (DOI Member)
- WorldCat
- Index Copernicus
- J-STAGE (Japan Science and Technology) | 科学技術情報発信・流通総合システム - Application in Process
Absolutely! IMJ Health actively welcomes research on Kampo (traditional Japanese medicine), iPS cell research, regenerative medicine, and all areas of Japanese medical excellence. Research on clinical trials, mechanism studies, and integrative medicine approaches is particularly encouraged.
- Regenerative medicine and iPS cell applications
- Evidence-based Kampo research and mechanism studies
- Cancer immunotherapy and precision oncology
- Dementia and aging-related research
- AI and digital health innovations
- Integrative medicine combining Kampo with modern medicine
Publication fees vary based on article type and length. We offer competitive rates for researchers from Japanese institutions. Many funding agencies, including AMED and JSPS, allow publication fees as part of research grants.
Academic Faculty | 教員
$100 (USD)
Approx. ¥ 15,000
Students/Scholars | 学生/研究者
$80 (USD)
Approx. ¥ 12,000
You can submit your article online via the Submit Article Link on the journal's homepage. You can also email your submission to info@imjhealth.org or info.imjh@gmail.com. Electronic submission helps reduce processing time and speeds up publication.
The official language of publication is English to ensure global accessibility. However, we understand that Japanese researchers may need language support. We offer assistance with English language editing and can help polish manuscripts before publication to ensure they meet international standards.
You can contact our editorial office through multiple channels:
LINE:
IMJHealth_Japan (for Japanese authors)
Response within 24 hours on business days | 営業日内24時間以内に返信
Join Japan's Leading Medical Researchers | 日本のトップ医学研究者に参加する
Share your research with the global medical community. IMJ Health is your trusted partner in advancing medical science from Japan to the world. | あなたの研究を世界の医学コミュニティと共有しましょう。IMJ Healthは、日本の医学を世界に発信する信頼できるパートナーです。
Submit Your Research | 研究論文を投稿する
Online Submission | オンライン投稿
https://imjhealth.org/submit-article
Fast, secure, and user-friendly submission portal | 迅速、安全、使いやすい投稿ポータル
Email Submission | メール投稿
info@imjhealth.org
info.imjh@gmail.com
For inquiries or direct submission | 問い合わせまたは直接投稿